Covid, carried out monoclonal antibodies in the EU: contract with Eli Lilly

A contract signed with Eli Lilly for the supply of monoclonal antibodies against Covid: the details


News for anti Covid based treatments monoclonal antibodies. The EU Commission has signed a joint procurement framework contract with the pharmaceutical company Eli Lilly to provide treatment for coronavirus patients. To announce it, as reported by Ansa, is the community executive itself.

The new contract, according to the EU, marks the “latest development” in the “first portfolio of five promising therapies announced by the Commission” in June as part of the Covid therapy strategy.

Eighteen Member States have already signed the joint contract for the purchase of a maximum of 220 thousand doses of the medicine currently under review by the EMA.

The agreement paves the way for a portfolio consisting of five promising therapies announced by the Commission as part of the EU therapeutic strategy against Covid-19. Among others, there are also treatments from GlaxoSmithKline Plc and Vir Biotechnology Inc, Regeneron Pharmaceuticals Inc, and Celltrion HealthCare Co.

“We must continue our work to prevent diseases with vaccines and at the same time make sure we can treat them with therapies,” said the EU Commissioner for Health. Stella Kyriakides.

Virgil News | 09-21-2021 21:54

Photo source: ANSA

Covid, monoclonal antibodies: what they are, how they work


Covid carried monoclonal antibodies contract Eli Lilly

PREV It’s a hunt for Caracas funds. Only in Italy is not investigated
NEXT tomorrow in Rome Fenimprese national assembly